share_log

Medical Marijuana, Inc. CEO Chosen To Present Oral Comments At FDA's Public Hearing On Products Containing Cannabis And Cannabis-Derived Compounds >MJNA

Dow Jones Newswires ·  May 21, 2019 13:00

*DJ Medical Marijuana, Inc. CEO Chosen To Present Oral Comments At FDA's Public Hearing On Products Containing Cannabis And Cannabis-Derived Compounds >MJNA

(MORE TO FOLLOW) Dow Jones Newswires (212-416-2800)

May 21, 2019 09:00 ET (13:00 GMT)

Copyright (c) 2019 Dow Jones & Company, Inc.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
3
Comment Comment · Views 1022

Recommended